speb/financial-data huggingface dataset:
CLSK balance_sheet (annual, 2024-09-30) — Dividends Payable: 0.00
CLSK income_statement (annual, 2024-09-30) — EBIT: -139978000.00
CLSK income_statement (annual, 2024-09-30) — EBITDA: 14631000.00
CLSK cash_flow (annual, 2024-09-30) — End Cash Position: 124278000.00
CLSK cash_flow (annual, 2024-09-30) — Financing Cash Flow: 1249123000.00
CLSK cash_flow (annual, 2024-09-30) — Free Cash Flow: -1040058000.00
CLSK cash_flow (annual, 2024-09-30) — Gain Loss On Investment Securities: -378003000.00
CLSK income_statement (annual, 2024-09-30) — Gain On Sale Of Ppe: -5466000.00
CLSK income_statement (annual, 2024-09-30) — Gain On Sale Of Security: -965000.00
CLSK balance_sheet (annual, 2024-09-30) — Gains Losses Not Affecting Retained Earnings: 418000.00
CLSK balance_sheet (quarterly, 2024-09-30) — Gains Losses Not Affecting Retained Earnings: 418000.00
CLSK income_statement (annual, 2024-09-30) — General And Administrative Expense: 43991000.00
CLSK balance_sheet (annual, 2024-09-30) — Goodwill: 8043000.00
CLSK balance_sheet (annual, 2024-09-30) — Goodwill And Other Intangible Assets: 11083000.00
CLSK balance_sheet (annual, 2024-09-30) — Gross PPE: 1729085000.00
CLSK income_statement (annual, 2024-09-30) — Gross Profit: 139357000.00
CLSK balance_sheet (annual, 2024-09-30) — Hedging Assets Current: 1832000.00
CLSK income_statement (annual, 2024-09-30) — Impairment Of Capital Assets: 197041000.00
CLSK income_statement (annual, 2024-09-30) — Interest Expense: 2455000.00
CLSK income_statement (annual, 2024-09-30) — Interest Expense Non Operating: 2455000.00
CLSK income_statement (annual, 2024-09-30) — Interest Income: 8555000.00
CLSK income_statement (annual, 2024-09-30) — Interest Income Non Operating: 8555000.00
CLSK cash_flow (annual, 2024-09-30) — Interest Paid Supplemental Data: 2126000.00
CLSK balance_sheet (annual, 2024-09-30) — Invested Capital: 1826795000.00
CLSK cash_flow (annual, 2024-09-30) — Investing Cash Flow: -920398000.00
CLSK balance_sheet (annual, 2024-09-30) — Investmentin Financial Assets: 0.00
CLSK balance_sheet (annual, 2024-09-30) — Investments And Advances: 0.00
CLSK cash_flow (annual, 2024-09-30) — Issuance Of Capital Stock: 1231834000.00
CLSK cash_flow (annual, 2024-09-30) — Issuance Of Debt: 50000000.00
CLSK balance_sheet (annual, 2024-09-30) — Land And Improvements: 37639000.00
CLSK balance_sheet (annual, 2024-09-30) — Leases: 1995000.00
CLSK balance_sheet (annual, 2024-09-30) — Long Term Capital Lease Obligation: 997000.00
CLSK balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 997000.00
CLSK balance_sheet (annual, 2024-09-30) — Long Term Debt: 7176000.00
CLSK balance_sheet (annual, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 8173000.00
CLSK cash_flow (annual, 2024-09-30) — Long Term Debt Issuance: 50000000.00
CLSK cash_flow (annual, 2024-09-30) — Long Term Debt Payments: -7358000.00
CLSK balance_sheet (annual, 2024-09-30) — Machinery Furniture Equipment: 16767000.00
CLSK cash_flow (annual, 2024-09-30) — Net Business Purchase And Sale: -18376000.00
CLSK cash_flow (annual, 2024-09-30) — Net Common Stock Issuance: 1231834000.00
CLSK income_statement (annual, 2024-09-30) — Net Income: -145777000.00
CLSK income_statement (annual, 2024-09-30) — Net Income Common Stockholders: -149199000.00
CLSK income_statement (annual, 2024-09-30) — Net Income Continuous Operations: -145777000.00
CLSK income_statement (annual, 2024-09-30) — Net Income Discontinuous Operations: 0.00
CLSK income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: 0.00
CLSK income_statement (annual, 2024-09-30) — Net Income From Continuing And Discontinued Operation: -145777000.00
CLSK income_statement (annual, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: -145777000.00
CLSK cash_flow (annual, 2024-09-30) — Net Income From Continuing Operations: -145777000.00
CLSK income_statement (annual, 2024-09-30) — Net Income Including Noncontrolling Interests: -145777000.00
CLSK cash_flow (annual, 2024-09-30) — Net Intangibles Purchase And Sale: 0.00
CLSK income_statement (annual, 2024-09-30) — Net Interest Income: 6100000.00
CLSK cash_flow (annual, 2024-09-30) — Net Investment Purchase And Sale: 43126000.00
CLSK cash_flow (annual, 2024-09-30) — Net Issuance Payments Of Debt: 42642000.00
CLSK cash_flow (annual, 2024-09-30) — Net Long Term Debt Issuance: 42642000.00
CLSK income_statement (annual, 2024-09-30) — Net Non Operating Interest Income Expense: 6100000.00
CLSK cash_flow (annual, 2024-09-30) — Net Other Financing Charges: -22685000.00
CLSK cash_flow (annual, 2024-09-30) — Net Other Investing Changes: -138752000.00
CLSK balance_sheet (annual, 2024-09-30) — Net PPE: 1232818000.00
CLSK cash_flow (annual, 2024-09-30) — Net PPE Purchase And Sale: -806396000.00
CLSK balance_sheet (annual, 2024-09-30) — Net Tangible Assets: 1749758000.00
CLSK balance_sheet (annual, 2024-09-30) — Non Current Deferred Liabilities: 5761000.00
CLSK balance_sheet (annual, 2024-09-30) — Non Current Deferred Taxes Liabilities: 5761000.00
CLSK income_statement (annual, 2024-09-30) — Normalized EBITDA: 218819000.00
CLSK income_statement (annual, 2024-09-30) — Normalized Income: 15531520.00
CLSK balance_sheet (annual, 2024-09-30) — Notes Receivable: 60919000.00
CLSK balance_sheet (quarterly, 2024-09-30) — Notes Receivable: 60919000.00
CLSK cash_flow (annual, 2024-09-30) — Operating Cash Flow: -233662000.00
CLSK cash_flow (annual, 2024-09-30) — Operating Gains Losses: -374012000.00
CLSK income_statement (annual, 2024-09-30) — Operating Income: -59243000.00
CLSK income_statement (annual, 2024-09-30) — Operating Revenue: 378968000.00
CLSK balance_sheet (annual, 2024-09-30) — Ordinary Shares Number: 270897784.00
CLSK balance_sheet (annual, 2024-09-30) — Other Current Assets: 7995000.00
CLSK balance_sheet (annual, 2024-09-30) — Other Current Liabilities: 2240000.00
CLSK balance_sheet (annual, 2024-09-30) — Other Equity Adjustments: 418000.00
CLSK balance_sheet (quarterly, 2024-09-30) — Other Equity Adjustments: 418000.00
CLSK income_statement (annual, 2024-09-30) — Other Gand A: 43991000.00
CLSK income_statement (annual, 2024-09-30) — Other Income Expense: -89290000.00
CLSK balance_sheet (annual, 2024-09-30) — Other Intangible Assets: 3040000.00
CLSK cash_flow (annual, 2024-09-30) — Other Non Cash Items: 1608000.00
CLSK balance_sheet (annual, 2024-09-30) — Other Non Current Assets: 13331000.00
CLSK income_statement (annual, 2024-09-30) — Other Non Operating Income Expenses: 114898000.00
CLSK balance_sheet (annual, 2024-09-30) — Other Properties: 158454000.00
CLSK balance_sheet (annual, 2024-09-30) — Other Receivables: 77827000.00
CLSK balance_sheet (quarterly, 2024-09-30) — Other Receivables: 77827000.00
CLSK balance_sheet (annual, 2024-09-30) — Other Short Term Investments: 432579000.00
CLSK income_statement (annual, 2024-09-30) — Other Taxes: 0.00
CLSK balance_sheet (annual, 2024-09-30) — Payables: 82992000.00
CLSK balance_sheet (annual, 2024-09-30) — Payables And Accrued Expenses: 126866000.00
CLSK balance_sheet (annual, 2024-09-30) — Preferred Shares Number: 1750000.00
CLSK balance_sheet (annual, 2024-09-30) — Preferred Stock: 3000.00
CLSK cash_flow (annual, 2024-09-30) — Preferred Stock Dividend Paid: -3421000.00
CLSK income_statement (annual, 2024-09-30) — Preferred Stock Dividends: 3422000.00
CLSK income_statement (quarterly, 2024-09-30) — Preferred Stock Dividends: 1000.00
CLSK balance_sheet (annual, 2024-09-30) — Preferred Stock Equity: 3000.00
CLSK income_statement (annual, 2024-09-30) — Pretax Income: -142433000.00
CLSK cash_flow (annual, 2024-09-30) — Proceeds From Stock Option Exercised: 753000.00
CLSK balance_sheet (annual, 2024-09-30) — Properties: 1058194000.00
CLSK cash_flow (annual, 2024-09-30) — Provisionand Write Offof Assets: 162000.00
CLSK cash_flow (annual, 2024-09-30) — Purchase Of Business: -18376000.00
CLSK cash_flow (annual, 2024-09-30) — Purchase Of Intangibles: 0.00
CLSK cash_flow (annual, 2024-09-30) — Purchase Of Investment: 0.00
CLSK cash_flow (annual, 2024-09-30) — Purchase Of PPE: -806396000.00
CLSK balance_sheet (annual, 2024-09-30) — Receivables: 138746000.00
CLSK income_statement (annual, 2024-09-30) — Reconciled Cost Of Revenue: 239611000.00
CLSK income_statement (annual, 2024-09-30) — Reconciled Depreciation: 154609000.00
CLSK cash_flow (annual, 2024-09-30) — Repayment Of Debt: -7358000.00
CLSK cash_flow (annual, 2024-09-30) — Repurchase Of Capital Stock: 0.00
CLSK balance_sheet (annual, 2024-09-30) — Restricted Cash: 3056000.00
CLSK income_statement (annual, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
CLSK income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
CLSK balance_sheet (annual, 2024-09-30) — Retained Earnings: -479218000.00
CLSK cash_flow (annual, 2024-09-30) — Sale Of Business: 0.00
CLSK cash_flow (annual, 2024-09-30) — Sale Of Investment: 43126000.00
CLSK cash_flow (annual, 2024-09-30) — Sale Of PPE: 1438000.00
CLSK income_statement (annual, 2024-09-30) — Selling General And Administration: 43991000.00
CLSK balance_sheet (annual, 2024-09-30) — Share Issued: 270897784.00
CLSK income_statement (annual, 2024-09-30) — Special Income Charges: -203223000.00
CLSK cash_flow (annual, 2024-09-30) — Stock Based Compensation: 29555000.00
CLSK balance_sheet (annual, 2024-09-30) — Stockholders Equity: 1760841000.00
CLSK balance_sheet (annual, 2024-09-30) — Tangible Book Value: 1749755000.00
CLSK income_statement (annual, 2024-09-30) — Tax Effect Of Unusual Items: -42879480.00
CLSK income_statement (annual, 2024-09-30) — Tax Provision: 3344000.00
CLSK income_statement (annual, 2024-09-30) — Tax Rate For Calcs: 0.21
CLSK balance_sheet (annual, 2024-09-30) — Total Assets: 1962662000.00
CLSK balance_sheet (annual, 2024-09-30) — Total Capitalization: 1768017000.00
CLSK balance_sheet (annual, 2024-09-30) — Total Debt: 66954000.00
CLSK balance_sheet (annual, 2024-09-30) — Total Equity Gross Minority Interest: 1760841000.00
CLSK income_statement (annual, 2024-09-30) — Total Expenses: 438211000.00
CLSK balance_sheet (annual, 2024-09-30) — Total Liabilities Net Minority Interest: 201821000.00
CLSK balance_sheet (annual, 2024-09-30) — Total Non Current Assets: 1257232000.00
CLSK balance_sheet (annual, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 13934000.00
CLSK income_statement (annual, 2024-09-30) — Total Operating Income As Reported: -149043000.00
CLSK income_statement (annual, 2024-09-30) — Total Unusual Items: -204188000.00
CLSK income_statement (annual, 2024-09-30) — Total Unusual Items Excluding Goodwill: -204188000.00
CLSK balance_sheet (annual, 2024-09-30) — Treasury Stock: 0.00
CLSK cash_flow (annual, 2024-09-30) — Unrealized Gain Loss On Investment Securities: -113423000.00
CLSK balance_sheet (annual, 2024-09-30) — Working Capital: 517543000.00
CLSK income_statement (annual, 2024-09-30) — Write Off: 716000.00
CLSK income_statement (quarterly, 2024-09-30) — Write Off: 320000.00
CLSK income_statement (quarterly, 2024-12-31) — Basic Average Shares: 284549900.00
CLSK income_statement (quarterly, 2024-12-31) — Basic EPS: 0.83
CLSK cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Operating Activities: 0.00
CLSK cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: -12477000.00
CLSK income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 297887140.00
CLSK income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.83
CLSK balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 5141000.00
CLSK balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 450000.00
CLSK balance_sheet (quarterly, 2024-12-31) — Notes Receivable: 0.00
CLSK balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 450000.00
CLSK balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 4618000.00
CLSK income_statement (quarterly, 2024-12-31) — Other Taxes: 0.00
CLSK income_statement (quarterly, 2024-12-31) — Preferred Stock Dividends: 5141000.00
CLSK cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 1411000.00
CLSK cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -260699000.00
CLSK income_statement (quarterly, 2025-03-31) — +Operating Expense: 93620000.00
CLSK income_statement (quarterly, 2025-03-31) — +Total Revenue: 181712000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 11390000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -371017000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2408160000.00
CLSK cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 968000.00
CLSK cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 968000.00
CLSK cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
CLSK income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 0.00
CLSK income_statement (quarterly, 2025-03-31) — Basic Average Shares: 280853882.00
CLSK income_statement (quarterly, 2025-03-31) — Basic EPS: -0.49
CLSK cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 280007000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 79764000.00
CLSK cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -34092000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Capital Stock: 295000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 96982000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 933568000.00
CLSK cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -5141000.00
CLSK cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -7377000.00
CLSK cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -59930000.00
CLSK cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -112283000.00
CLSK cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: 0.00
CLSK cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -193000.00
CLSK cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -3700000.00
CLSK cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -827000.00
CLSK cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 7757000.00
CLSK cash_flow (quarterly, 2025-03-31) — Changes In Cash: -179590000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Common Stock: 293000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1890489000.00
CLSK cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 1000.00
CLSK cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
CLSK balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 161648000.00
CLSK income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 100679000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 87906000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Current Assets: 947493000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Current Debt: 5420000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 5420000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 109312000.00
CLSK cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -3044000.00
CLSK cash_flow (quarterly, 2025-03-31) — Deferred Tax: -3044000.00
CLSK cash_flow (quarterly, 2025-03-31) — Depreciation: 77933000.00
CLSK cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 78901000.00
CLSK income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 78901000.00
CLSK cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 78901000.00
CLSK income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 78901000.00
CLSK income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 280853882.00
CLSK income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.49
CLSK income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -138792000.00
CLSK income_statement (quarterly, 2025-03-31) — EBIT: -140568000.00
CLSK income_statement (quarterly, 2025-03-31) — EBITDA: -61667000.00
CLSK cash_flow (quarterly, 2025-03-31) — End Cash Position: 100417000.00
CLSK cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -7377000.00
CLSK cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -146375000.00
CLSK cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 4741000.00
CLSK income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 2230000.00
CLSK income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -4741000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 3396000.00
CLSK income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 14719000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Goodwill: 132216000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 139194000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1770983000.00
CLSK income_statement (quarterly, 2025-03-31) — Gross Profit: 81033000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 72000.00
CLSK income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 0.00
CLSK income_statement (quarterly, 2025-03-31) — Interest Expense: 1267000.00
CLSK income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1267000.00
CLSK income_statement (quarterly, 2025-03-31) — Interest Income: 2014000.00
CLSK income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 2014000.00
CLSK cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 490000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2537649000.00
CLSK cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -59930000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 146945000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 146945000.00
CLSK cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 1000.00
CLSK cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
CLSK balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 45155000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Leases: 2471000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 641740000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 641740000.00
CLSK cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
CLSK cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -2281000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 18483000.00
CLSK cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 37433000.00
CLSK cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 1000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Net Debt: 550178000.00
CLSK income_statement (quarterly, 2025-03-31) — Net Income: -138792000.00
CLSK income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -138792000.00
CLSK income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -138792000.00
CLSK income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -138792000.00
CLSK income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -138792000.00
CLSK cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -138792000.00
CLSK income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -138792000.00
CLSK income_statement (quarterly, 2025-03-31) — Net Interest Income: 747000.00
CLSK cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
CLSK cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -2281000.00
CLSK cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -2281000.00
CLSK income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 747000.00
CLSK cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 0.00
CLSK cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -61860000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Net PPE: 1399966000.00
CLSK cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -35503000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1751297000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 11934000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 11934000.00
CLSK income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -59156000.00
CLSK income_statement (quarterly, 2025-03-31) — Normalized Income: -136333731.00
CLSK balance_sheet (quarterly, 2025-03-31) — Notes Receivable: 0.00
CLSK cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -112283000.00
CLSK cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 2511000.00
CLSK income_statement (quarterly, 2025-03-31) — Operating Income: -12587000.00
CLSK income_statement (quarterly, 2025-03-31) — Operating Revenue: 181712000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 280900178.00
CLSK balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 10418000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 4596000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 3396000.00
CLSK income_statement (quarterly, 2025-03-31) — Other Gand A: 14719000.00
CLSK income_statement (quarterly, 2025-03-31) — Other Income Expense: -129995000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 6978000.00
CLSK cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -190384000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 23400000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 3521000.00
CLSK income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -127484000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Other Properties: 252741000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 836586000.00
CLSK income_statement (quarterly, 2025-03-31) — Other Taxes: 0.00
CLSK balance_sheet (quarterly, 2025-03-31) — Payables: 11390000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 99296000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 1750000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 2000.00
CLSK cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: -5141000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 2000.00
CLSK income_statement (quarterly, 2025-03-31) — Pretax Income: -141835000.00
CLSK cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 44000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Properties: 1210721000.00
CLSK cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -5490000.00
CLSK cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
CLSK cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -34092000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Receivables: 0.00
CLSK income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 100679000.00
CLSK income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 78901000.00
CLSK cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -2281000.00
CLSK cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CLSK balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 3435000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -376360000.00
CLSK income_statement (quarterly, 2025-03-31) — Salaries And Wages: 15255000.00
CLSK cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
CLSK income_statement (quarterly, 2025-03-31) — Selling General And Administration: 14719000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Share Issued: 292660113.00
CLSK income_statement (quarterly, 2025-03-31) — Special Income Charges: 2230000.00
CLSK cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 3101000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1890491000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1751295000.00
CLSK income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -52731.00
CLSK income_statement (quarterly, 2025-03-31) — Tax Provision: -3043000.00
CLSK income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.02
CLSK balance_sheet (quarterly, 2025-03-31) — Total Assets: 2656998000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2532231000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Total Debt: 647160000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1890491000.00
CLSK income_statement (quarterly, 2025-03-31) — Total Expenses: 194299000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 766507000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1709505000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 657195000.00
CLSK income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -138024000.00
CLSK income_statement (quarterly, 2025-03-31) — Total Unusual Items: -2511000.00
CLSK income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -2511000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 11759935.00
CLSK balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 145000000.00
CLSK cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 127667000.00
CLSK balance_sheet (quarterly, 2025-03-31) — Working Capital: 838181000.00
CLSK income_statement (quarterly, 2025-03-31) — Write Off: 0.00
CLSK income_statement (quarterly, 2025-06-30) — +Operating Expense: 114450000.00
CLSK income_statement (quarterly, 2025-06-30) — +Total Revenue: 198644000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 23470000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -483305000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 2412993000.00
CLSK cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 1022000.00
CLSK cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 1022000.00
CLSK cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
CLSK income_statement (quarterly, 2025-06-30) — Basic Average Shares: 280997649.00
CLSK income_statement (quarterly, 2025-06-30) — Basic EPS: 0.90
CLSK cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 100417000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 91783000.00
CLSK cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -42535000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Capital Stock: 295000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 34553000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 916025000.00
CLSK cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
CLSK cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 172763000.00
CLSK cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -125277000.00
CLSK cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -109888000.00
CLSK cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Operating Activities: 0.00
CLSK cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -315000.00
CLSK cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 9926000.00
CLSK cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -2259000.00
CLSK cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 7352000.00
CLSK cash_flow (quarterly, 2025-06-30) — Changes In Cash: -62402000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Common Stock: 293000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2146886000.00
CLSK cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
CLSK cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
CLSK balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 213331000.00
CLSK income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 106526000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 64492000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Current Assets: 1210140000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Current Debt: 176424000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 176424000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 276819000.00
CLSK cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 18108000.00
CLSK cash_flow (quarterly, 2025-06-30) — Deferred Tax: 18108000.00
CLSK cash_flow (quarterly, 2025-06-30) — Depreciation: 93858000.00
CLSK cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 94880000.00
CLSK income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 94880000.00
CLSK cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 94880000.00
CLSK income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 94880000.00
CLSK income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 325594451.00
CLSK income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.78
CLSK income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 251787000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 5603000.00
CLSK income_statement (quarterly, 2025-06-30) — EBIT: 278951000.00
CLSK income_statement (quarterly, 2025-06-30) — EBITDA: 373831000.00
CLSK cash_flow (quarterly, 2025-06-30) — End Cash Position: 38015000.00
CLSK cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 172763000.00
CLSK cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -152423000.00
CLSK cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -432607000.00
CLSK cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 156000.00
CLSK income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: -156000.00
CLSK income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -430000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 3173000.00
CLSK income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 19570000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Goodwill: 128810000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 135765000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2013465000.00
CLSK income_statement (quarterly, 2025-06-30) — Gross Profit: 92118000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 7843000.00
CLSK income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
CLSK income_statement (quarterly, 2025-06-30) — Interest Expense: 3454000.00
CLSK income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 3454000.00
CLSK income_statement (quarterly, 2025-06-30) — Interest Income: 355000.00
CLSK income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 355000.00
CLSK cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 2686000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2967223000.00
CLSK cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -125277000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 202687000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 202687000.00
CLSK cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CLSK cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 176500000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 48989000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Leases: 2941000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 643913000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 643913000.00
CLSK cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 176500000.00
CLSK cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -4082000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 18755000.00
CLSK cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -1504000.00
CLSK cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CLSK balance_sheet (quarterly, 2025-06-30) — Net Debt: 785784000.00
CLSK income_statement (quarterly, 2025-06-30) — Net Income: 257390000.00
CLSK income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 251787000.00
CLSK income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 257390000.00
CLSK income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 257390000.00
CLSK income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 257390000.00
CLSK cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 257390000.00
CLSK income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 257390000.00
CLSK income_statement (quarterly, 2025-06-30) — Net Interest Income: -3099000.00
CLSK cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 45882000.00
CLSK cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 172418000.00
CLSK cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 172418000.00
CLSK income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -3099000.00
CLSK cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
CLSK cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -128531000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Net PPE: 1530160000.00
CLSK cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -41124000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2011123000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 30774000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 30774000.00
CLSK income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 374417000.00
CLSK income_statement (quarterly, 2025-06-30) — Normalized Income: 257937324.00
CLSK balance_sheet (quarterly, 2025-06-30) — Notes Receivable: 0.00
CLSK cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -109888000.00
CLSK cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -432451000.00
CLSK income_statement (quarterly, 2025-06-30) — Operating Income: -22332000.00
CLSK income_statement (quarterly, 2025-06-30) — Operating Revenue: 198644000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 281063551.00
CLSK balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 11319000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 6830000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 3173000.00
CLSK income_statement (quarterly, 2025-06-30) — Other Gand A: 19570000.00
CLSK income_statement (quarterly, 2025-06-30) — Other Income Expense: 300928000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 6955000.00
CLSK cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -192686000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 23065000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 3423000.00
CLSK income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 301514000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Other Properties: 292237000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Other Receivables: 271491000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 881472000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Payables: 29073000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 93565000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 1750000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 2000.00
CLSK cash_flow (quarterly, 2025-06-30) — Preferred Stock Dividend Paid: 0.00
CLSK income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 5603000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 2000.00
CLSK income_statement (quarterly, 2025-06-30) — Pretax Income: 275497000.00
CLSK cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 345000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Properties: 1345429000.00
CLSK cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -1413000.00
CLSK cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -82152000.00
CLSK cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -42535000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Receivables: 271491000.00
CLSK income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 106526000.00
CLSK income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 94880000.00
CLSK cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -4082000.00
CLSK cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
CLSK balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 3462000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -124573000.00
CLSK cash_flow (quarterly, 2025-06-30) — Sale Of Business: -91000.00
CLSK cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 128034000.00
CLSK income_statement (quarterly, 2025-06-30) — Selling General And Administration: 19570000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Share Issued: 292823486.00
CLSK income_statement (quarterly, 2025-06-30) — Special Income Charges: -156000.00
CLSK cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 4487000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2146888000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2011121000.00
CLSK income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -38676.00
CLSK income_statement (quarterly, 2025-06-30) — Tax Provision: 18107000.00
CLSK income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.07
CLSK balance_sheet (quarterly, 2025-06-30) — Total Assets: 3101817000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2790801000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Total Debt: 820337000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2146888000.00
CLSK income_statement (quarterly, 2025-06-30) — Total Expenses: 220976000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 954929000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1891677000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 678110000.00
CLSK income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 246163000.00
CLSK income_statement (quarterly, 2025-06-30) — Total Unusual Items: -586000.00
CLSK income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -586000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 11759935.00
CLSK balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 145000000.00
CLSK balance_sheet (quarterly, 2025-06-30) — Working Capital: 933321000.00
CLSK income_statement (quarterly, 2025-06-30) — Write Off: 0.00
CLSK income_statement (annual, 2025-09-30) — +Operating Expense: 425867000.00
CLSK income_statement (quarterly, 2025-09-30) — +Operating Expense: 137629000.00
CLSK income_statement (annual, 2025-09-30) — +Total Revenue: 766314000.00
CLSK income_statement (quarterly, 2025-09-30) — +Total Revenue: 223652000.00
CLSK balance_sheet (annual, 2025-09-30) — Accounts Payable: 15159000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 15159000.00
CLSK balance_sheet (annual, 2025-09-30) — Accumulated Depreciation: -559943000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -559943000.00
CLSK balance_sheet (annual, 2025-09-30) — Additional Paid In Capital: 2445723000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 2445723000.00
CLSK cash_flow (annual, 2025-09-30) — Amortization Cash Flow: 4200000.00
CLSK cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 1106000.00
CLSK cash_flow (annual, 2025-09-30) — Amortization Of Intangibles: 4200000.00
CLSK cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 1106000.00
CLSK cash_flow (annual, 2025-09-30) — Asset Impairment Charge: 0.00
CLSK cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
CLSK income_statement (annual, 2025-09-30) — Basic Average Shares: 282182800.00
CLSK income_statement (annual, 2025-09-30) — Basic EPS: 1.25
CLSK cash_flow (annual, 2025-09-30) — Beginning Cash Position: 124278000.00
CLSK cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 38015000.00
CLSK balance_sheet (annual, 2025-09-30) — Buildings And Improvements: 96400000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 96400000.00
CLSK cash_flow (annual, 2025-09-30) — Capital Expenditure: -562873000.00
CLSK cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -428887000.00
CLSK balance_sheet (annual, 2025-09-30) — Capital Lease Obligations: 3281000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 3281000.00
CLSK balance_sheet (annual, 2025-09-30) — Capital Stock: 298000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Capital Stock: 298000.00
CLSK balance_sheet (annual, 2025-09-30) — Cash And Cash Equivalents: 42966000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 42966000.00
CLSK balance_sheet (annual, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1009795000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1009795000.00
CLSK cash_flow (annual, 2025-09-30) — Cash Dividends Paid: -10744000.00
CLSK cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -5603000.00
CLSK cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Financing Activities: 688866000.00
CLSK cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -7648000.00
CLSK cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Investing Activities: -305656000.00
CLSK cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 135498000.00
CLSK cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Operating Activities: -461032000.00
CLSK cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -119409000.00
CLSK cash_flow (annual, 2025-09-30) — Cash From Discontinued Investing Activities: 0.00
CLSK cash_flow (annual, 2025-09-30) — Cash From Discontinued Operating Activities: 0.00
CLSK cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Operating Activities: 0.00
CLSK cash_flow (annual, 2025-09-30) — Change In Other Current Assets: -7162000.00
CLSK cash_flow (annual, 2025-09-30) — Change In Other Current Liabilities: -1072000.00
CLSK cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -416000.00
CLSK cash_flow (annual, 2025-09-30) — Change In Payables And Accrued Expense: 32794000.00
CLSK cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 31222000.00
CLSK cash_flow (annual, 2025-09-30) — Change In Prepaid Assets: -5057000.00
CLSK cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -1171000.00
CLSK cash_flow (annual, 2025-09-30) — Change In Working Capital: 19503000.00
CLSK cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 22473000.00
CLSK cash_flow (annual, 2025-09-30) — Changes In Cash: -77822000.00
CLSK cash_flow (quarterly, 2025-09-30) — Changes In Cash: 8441000.00
CLSK balance_sheet (annual, 2025-09-30) — Common Stock: 296000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Common Stock: 296000.00
CLSK balance_sheet (annual, 2025-09-30) — Common Stock Equity: 2175125000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2175125000.00
CLSK cash_flow (annual, 2025-09-30) — Common Stock Issuance: 186808000.00
CLSK cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CLSK cash_flow (annual, 2025-09-30) — Common Stock Payments: -145000000.00
CLSK cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
CLSK balance_sheet (annual, 2025-09-30) — Construction In Progress: 124825000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 124825000.00
CLSK income_statement (annual, 2025-09-30) — Cost Of Revenue: 447480000.00
CLSK income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 149116000.00
CLSK balance_sheet (annual, 2025-09-30) — Current Accrued Expenses: 117544000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 117544000.00
CLSK balance_sheet (annual, 2025-09-30) — Current Assets: 1320041000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Current Assets: 1320041000.00
CLSK balance_sheet (annual, 2025-09-30) — Current Debt: 176570000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Current Debt: 176570000.00
CLSK balance_sheet (annual, 2025-09-30) — Current Debt And Capital Lease Obligation: 176570000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 176570000.00
CLSK balance_sheet (annual, 2025-09-30) — Current Liabilities: 315765000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 315765000.00
CLSK cash_flow (annual, 2025-09-30) — Deferred Income Tax: 39111000.00
CLSK cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 14830000.00
CLSK cash_flow (annual, 2025-09-30) — Deferred Tax: 39111000.00
CLSK cash_flow (quarterly, 2025-09-30) — Deferred Tax: 14830000.00
CLSK cash_flow (annual, 2025-09-30) — Depreciation: 344135000.00
CLSK cash_flow (quarterly, 2025-09-30) — Depreciation: 107219000.00
CLSK cash_flow (annual, 2025-09-30) — Depreciation Amortization Depletion: 348335000.00
CLSK cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 108325000.00
CLSK income_statement (annual, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 348335000.00
CLSK income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 108325000.00
CLSK cash_flow (annual, 2025-09-30) — Depreciation And Amortization: 348335000.00
CLSK cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 108325000.00
CLSK income_statement (annual, 2025-09-30) — Depreciation And Amortization In Income Statement: 348335000.00
CLSK income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 108325000.00
CLSK income_statement (annual, 2025-09-30) — Diluted Average Shares: 317761220.00
CLSK income_statement (annual, 2025-09-30) — Diluted EPS: 1.12
CLSK income_statement (annual, 2025-09-30) — Diluted NI Availto Com Stockholders: 353324000.00
CLSK income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -1321000.00
CLSK balance_sheet (annual, 2025-09-30) — Dividends Payable: 396000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 396000.00
CLSK income_statement (annual, 2025-09-30) — EBIT: 414910000.00
CLSK income_statement (quarterly, 2025-09-30) — EBIT: 18960000.00
CLSK income_statement (annual, 2025-09-30) — EBITDA: 763245000.00
CLSK income_statement (quarterly, 2025-09-30) — EBITDA: 127285000.00
CLSK cash_flow (annual, 2025-09-30) — End Cash Position: 46456000.00
CLSK cash_flow (quarterly, 2025-09-30) — End Cash Position: 46456000.00
CLSK cash_flow (annual, 2025-09-30) — Financing Cash Flow: 688866000.00
CLSK cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -7648000.00
CLSK cash_flow (annual, 2025-09-30) — Free Cash Flow: -1023905000.00
CLSK cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -548296000.00
CLSK cash_flow (annual, 2025-09-30) — Gain Loss On Investment Securities: -764768000.00
CLSK cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -333280000.00
CLSK income_statement (annual, 2025-09-30) — Gain On Sale Of Ppe: 336000.00